Patent: 5,814,605
✉ Email this page to a colleague
Summary for Patent: 5,814,605
| Title: | Therapeutic uses of keratinocyte growth factor |
| Abstract: | Based on extensive in vivo studies in animals, it has now been discovered that KGF stimulates proliferation, growth and differentiation in various cells of epithelial tissue, besides keratinocytes. This better understanding of the biological effects of KGF in vivo enables the use of this polypeptide as a therapeutic agent, suitably formulated in a pharmaceutical composition, for the specific treatment of disease states and medical conditions afflicting tissues and organs such as the dermal adnexae, the liver, the lung, and the gastrointestinal tract. |
| Inventor(s): | Pierce; Glenn Francis (Rancho Santa Fe, CA), Housley; Regina Mae (Thousand Oaks, CA), Morris; Charles Frederick (Newbury Park, CA) |
| Assignee: | Amgen Inc. (Thousand Oaks, CA) |
| Application Number: | 08/484,065 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,814,605
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Swedish Orphan Biovitrum Ab (publ) | KEPIVANCE | palifermin | For Injection | 125103 | 12/15/2004 | ⤷ Try a Trial | 2015-09-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,814,605
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | 183233 | ⤷ Try a Trial |
| Australia | 6524394 | ⤷ Try a Trial |
| Australia | 707340 | ⤷ Try a Trial |
| Canada | 2159109 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
